Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

STI-571 enhances potency of antileukemic therapies against Bcr-Abl-expressing cells

Oct. 13, 2000

Procyon and Biovation enter cancer immunotherapy agreement

Oct. 13, 2000

Antitumor agents patented by Japanese researchers

Oct. 11, 2000

Recent patent covers new inhibitors of specific MMPs

Oct. 11, 2000

Novel target for anticancer therapy and new compounds discovered at Klinge

Oct. 10, 2000

CRL-8256, with potential in cancer chemotherapy, emerges from joint French and Belgian research

Oct. 10, 2000

Coulter's Bexxar assigned priority review status by FDA

Oct. 10, 2000

Myriad reports location of prostate cancer susceptibility gene

Oct. 10, 2000

Clinical trial results for IL-2/SEB combination therapy for melanoma positive

Oct. 10, 2000

Potent topoisomerase inhibitors related to camptothecin described in recent patent

Oct. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...